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ABSTRACT 
Background: Previous prospective cohort studies have examined the association between 
smoking and the risk of dementia, but the results were inconsistent. Methods: A prospective, 
nested, case-control study was conducted to examine the association between cigarette 
smoking and risk of disabling dementia within the cohort of 6,343 men and women aged 
35–85 years. Incident dementia was documented in 208 men and women (95 cases with and 
113 cases without history of stroke). Two control subjects per case were selected by matching 
for sex, age and year of examination. Results: The multivariable odds ratios (95% CI) for 
current versus never-smokers were 2.3 (1.1-4.7) for total dementia, 2.6 (0.8-8.2) for dementia 
with history of stroke and 2.2 (0.8-5.7) for dementia without it, yielding no effect of stroke 
history on the smoking-dementia association. A dose-response relationship was noted 
between the years of cigarettes smoking and the risk of total dementia and a significant excess 
risk was found for smokers of >45 years in duration. Conclusions: The present prospective 
study suggests that a long-term cigarettes smoking may raise the risk of disabling dementia. 
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Background 
Dementia has become a major health problem in Japan, as well as in Western countries, 
because of the sharp increase in the number of elderly individuals.1 Stroke produces decline in 
cognitive functions and dementia 2, and the traditional risk factors for cardiovascular disease, 
such as hypertension 2-5, high cholesterol 3,5, and diabetes 2,5 are associated with increased 
risks for both Alzheimer’s disease and vascular dementia. By contrast, the contribution of 
smoking, major risk factor for cardiovascular disease, to dementia is less clear. Several 
previous case–control studies have indicated that smoking is associated with a reduced risk of 
dementia.6 However, this inverse association between smoking and dementia might have been 
caused by the introduction of differential survival biases.6,7 Smokers are likely to have been 
under-represented in these studies because of their increased risk of early death from 
cardiovascular disease and cancer.8 In addition, individuals with dementia might have tended 
to under-report their smoking habits.6,7 These biases could have distorted the reported 
associations between smoking and dementia.6,7 Thus, owing to the methodological limitations 
of case–control studies, there is a requirement for prospective studies to examine the 
association between smoking and dementia. 
Some recent prospective cohort studies have suggested that smokers have an 
approximately 1.4-fold to 1.7-fold increased risk of dementia compared with individuals who 
have never smoked,6,9–11 although other studies of this type have shown no such association.6 
The aim of the present nested case–control study was to investigate the association between 
cigarette smoking and the risk of disabling dementia using prospective data from members of 
a Japanese rural community. 
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MATERIALS AND METHODS 
 
The study cohort was established in the town of Kyowa (Ibaraki Prefecture, Japan) in 1981 
for community-based cardiovascular prevention program. The design of the cohort study has 
been described previously. 12,13 This cohort has been followed up with annual cardiovascular 
surveys, and surveillance for incidence and mortality of stroke and coronary heart disease. 
Within this cohort, elderly persons aged >65 years with disabling dementia, requiring for care 
were identified under the national long-term care insurance program, between April 1, 2000 
and March 31, 2004. We did not have information on cognitive function prior to dementia. 
However, in order to reduce the potential effects of as yet undiagnosed dementia at the time of 
a given cardiovascular survey, the cohort included 6,343 men and women aged 35–85 years 
who participated in the surveys between 1981 and 1994 (of these, 4,085 subjects were over 65 
years old between 2000 and 2004). Of these, 1,156 subjects were died, 252 subjects were 
moved out of study area before March 31, 2004. The overall participation rate was 70%. The 
Ethics Committee of the University of Tsukuba, Japan, approved the study procedures. 
 
Long-term care insurance program for elderly aged >65 
The details of the national long-term care insurance program for elderly aged >65 have been 
reported elsewhere.14,15 In brief, the insurance program was started in Japan from April 2000. 
This program was essentially extended from the national health insurance system, and 
partially relied on subsides from general revenues from national, prefectures and 
municipalities. All individuals aged >40 are required to pay a supplement to their health 
insurance, which is transferred to the long-term care. The payment is directly withdrawn from 
their monthly income, shared with the employer or deducted from their public pensions. All 
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individuals are able to receive a long-term care through their resided municipals when they 
become 65 and older and also have disabling dementia and/or reduced activity of daily living. 
Case-control analysis 
Case selection 
The cases were selected among the subjects aged >65 years between 2000 and 2004 who were 
regarded as suffering from dementia under the long-term insurance program. The dementia 
status were classified into six-ranks (0-V) and were reported by their primary care physicians 
according to the standardized physicians’ manual issued by the Health and Welfare Bureau 
for the Elderly of Japan.16 The dementia status were annually updated and were reviewed until 
they were withdrawn due to death or moving out of the study area. Individuals without 
dementia were classified as rank 0. Individuals who were diagnosed with mild cognitive 
dysfunction, but who had no dementia-related symptoms or behavioural disturbance and were 
capable of living independently, were classified as rankⅠ. Individuals who had moderate 
dementia-related behavioural disturbance and cognitive impairment with slight dependence 
were classified as rankⅡ. Individuals who had moderate-to-severe dementia-related 
behavioural disturbance and cognitive impairment with moderate dependence were classified 
as rankⅢ. Individuals who had severe dementia-related behavioural disturbance and 
cognitive impairment with heavy dependence were classified as rankⅣ. Finally, individuals 
with severe dementia-related behavioural disturbance and cognitive impairment who required 
medical treatment were classified as rankⅤ. Individuals who were ranked asⅡor greater for 
the first time were regarded as cases in the present analysis. The validation for the cut-off 
point was examined by neuropsychiatrists through the subjects’ cognitive functions (attention, 
memory, visuospatial function, language and reasoning) based on their ageing-associated 
cognitive decline (AACD), as defined by the International Psychogeriatric Association.17 The 
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calculated sensitivity and specificity values from the validation study of 34 subjects were 36% 
and 90%, respectively.  
History of stroke identification 
The history of stroke was obtained from the annual cardiovascular surveys, surveillance for 
cardiovascular disease 13 from 1981 to the present, and/or statements from the primary care 
physicians. In present study, 85% of the stroke history was confirmed based on CT or MRI 
using standardized criteria. 18 The determination of stroke history without the imaging studies 
was conducted based on the clinical criteria.19 Stroke was defined as rapid onset focal 
neurological disorder persisting for > 24h, or until death. Transient ischemic attack was not 
included. 
Control selection 
We employed the risk-set sampling 20of controls, i.e., matching randomly each case of 
dementia with two of all other individuals with no diagnosis of dementia in the study cohort 
who were alive and resided within the community on the date of diagnosis of dementia for the 
case and who had the same gender, year of given annual cardiovascular survey and age (±2 
years) as the case. The vital status of controls was assessed before the control selection. 
Measurement of risk factors 
Participants were interviewed smoking status (current, past, or never); those who smoked 
cigarettes were asked their age at start of smoking and the average daily number of cigarettes 
smoked at the time of a given annual cardiovascular survey. Those who had not smoked for 3 
months or more were defined as past smokers. The past smokers were asked for their age at 
starting and quitting smoking, and the average daily number of cigarettes smoked. For each 
case, the latest measurements from a given survey between 1981 and 1994 were selected for 
the analysis. For controls, the measurements included in the analysis were selected from the 
same year of a given survey as the case. 
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The reliability of smoking questionnaire was tested in the same population. The 
proportion of upholding the same smoking status at 1 year after the time of a given survey 
between 1981 and 1994 (n=2314) was 97% for never-smokers, 87% for past smokers, 93% 
for current smokers (83% for smokers of <20 cigarettes per day, and 75% for smokers of >20 
cigarettes per day).  
Confounding variables included systolic blood pressure (mmHg), use of 
antihypertensive medication (yes and no), body mass index (BMI) (kg/ m2), atrial fibrillation 
(Minnesota Codes 8-3-1 or 8-3-2), ST-T changes (Minnesota 4-1 to 4-3 or 5-1 to 5-3), ethanol 
intake (never-drinkers, ex-drinkers, or current drinkers), serum cholesterol (mmol/L), and 
diabetes mellitus (a fasting glucose level of >7.0 mmol/l, a non-fasting glucose level of >11.1 
mmol/l, or the use of medication for diabetes). 
 
Statistical Analysis 
The paired Student’s t-test was used to compare the values of baseline potential confounding 
factors and smoking status between incident cases and control subjects. The chi-square test 
was used to compare proportions of cases and control subjects. The odds ratios of total and 
subtypes of dementia were estimated according to the smoking status, tertiles of smoking 
years and tertiles of pack-years of smoking using the conditional logistic regression model. 
Adjustments for systolic blood pressure (mmHg), use of antihypertensive medication (yes vs. 
no), BMI (kg/m2), alcohol intake (non-current drinkers vs. current drinkers), atrial fibrillation 
(yes vs. no), ST-T abnormalities (yes vs. no), serum total cholesterol (mmol/L), and diabetes 
mellitus (yes vs. no) were applied for multivariable analysis. A trend across the categories for 
smoking years and pack-years of smoking was conducted by assigning median values for 
each category. To examine effect modification, we conducted stratified analyses according to 
sex and use of antihypertensive medication (yes and no), and checked statistical interactions 
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by using cross-product terms of smoking status and stratifying variables. The presence of sex 
interaction for the associations between smoking and risk of dementia was tested using 
cross-product terms of smoking status and sex variables. All p-values for statistical tests were 
two-tailed and values <0.05 were considered to reflect significant difference. All analyses 
were conducted using the SAS statistical package version 8.2 (SAS Institute Inc., Cary, NC). 
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RESULTS 
 
During 2000 to 2004, we identified 208 dementia cases, comprising 95 dementia cases with 
history of stroke and 113 dementia cases without such history.  
Table 1 shows the risk characteristics of dementia cases and control subjects. The 
average age at the time of a given an annual cardiovascular survey and physical examination 
during 1981 to 1994 was 69 years for total and subtypes of dementia, and 68-69 years for 
controls. The proportion of men was 36% for total dementia, 43% for dementia with history 
of stroke, 30% for without such history, and 30 to 43% for controls. The proportions of 
current smokers were higher for total dementia for controls. The prevalence of hypertension, 
diabetes, and ST-T abnormalities was higher for total and subtypes of dementia than for 
controls. These case-control differences were more evident for dementia with history of stroke 
than for dementia without such history.  
Table 2 shows age-, sex-, and survey-year-matched and multivariable adjusted odds 
ratios (95%CI) for total and subtypes of dementia according to smoking status. The 
multivariable odds ratios for current versus never-smokers were 2.3 (1.1-4.7) for total 
dementia, 2.4 (0.8-7.7) for dementia with history of stroke and 2.3 (0.9-6.0) for dementia 
without it. There was no significant excess risk among past smokers. We further analyzed the 
data by stratifying current smokers into two categories; <20 and >20 cigarettes/day and found 
a dose-response relationship for total dementia.  
We also analyzed the data by stratifying past and current smokers into three categories 
according to the number of years of and the pack-years of smoking, and found a 
dose-response relationship with the number of years of smoking and risk of total dementia (p 
for trend = 0.04), but not with the pack-years of smoking (p for trend = 0.21) (Table3). The 
Page 9 
dose-response relationship with the number of years of smoking was more pronounced for 
dementia with history of stroke although the excess risk did not reach statistical significance.  
We examined for potential effect modification by stratifying the analyses for sex and use of 
antihypertesive medication (yes and no) (data not shown). There were no statistically 
significant interactions between smoking status and sex (p for interaction=0.43) or use of 
antihypertesive medication (p for interaction=0.80) for total dementia.  
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DISCUSSION 
 
Our prospective study was the first to show that current smoking was associated with a 
two-fold increase in the risk of disabling dementia among Japanese. The association between 
smoking and risk of disabling dementia did not vary between persons with and without 
history of stroke. The Pooled European Studies of Dementia reported that current smokers 
had an increased risk of total dementia (relative risk [RR]=1.4; 95% confidence interval 
[CI]=1.0–1.9) and Alzheimer’s disease (RR=1.7; 95% CI=1.2–2.5) compared with individuals 
who had never smoked.9 Another prospective study of mixed ethnic groups 
(African-Americans, whites and Hispanics) in the USA reported that current smokers had an 
increased risk of Alzheimer’s disease (RR=1.7; 95% CI=1.1–2.8) compared with those who 
had never smoked.10 The Honolulu–Asia Ageing Study reported that current smokers had an 
increased risk of vascular dementia (odds ratio [OR]=1.7; 95% CI=1.0–2.9), but not for 
Alzheimer’s disease, compared with those who had never smoked; however, this association 
was no longer significant after adjustment for cardiovascular and respiratory factors.11  
A previous prospective study in Japan showed an association between smoking and 
increased risk of mortality from dementia.21 That study followed 265,118 individuals aged 
>40 years over a period of 17 years, and documented 69 deaths from senile dementia with 
cerebrovascular lesions and 120 deaths from senile dementia without cerebrovascular lesions. 
The age-adjusted RR of senile dementia without cerebrovascular lesions for current smokers 
compared with never smokers was 1.6 (90% CI=1.1–2.4), but no association was found 
between dementia with cerebrovascular lesions. However, that study did not adjust for 
potential confounding variables including blood pressure levels, and the diagnosis of 
dementia was not validated because the diagnosis relied only on death certificates. 
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A previous study found that the higher pack-year exposure was associated with greater 
cognitive decline among current and former smokers. 22 We found no significant association 
between the pack-year exposure and risk of total dementia, either dementia with or without 
history of stroke. However, we found an association between the number of years of smoking 
and the risk of total dementia, which may suggest that a long-term exposure rather than a high 
dose of smoking may increase the risk. 
Several mechanisms could account for the adverse effect of smoking on the risk of 
vascular dementia. Smoking causes arterio-atherosclerosis by directly injuring endothelial 
cells,23 it reduces high-density lipoprotein cholesterol levels,24 and it accelerates thrombus 
formation by increasing plasma fibrinogen 25 and platelet aggregability 26, decreasing 
fibrinolytic activities,27 increasing hematocrit 28 and reducing blood flow in the brain due to 
vasoconstriction.29  
Considering the association between smoking and Alzheimer’s disease, a previous 
case–reference study showed that patients with this disorder and a history of smoking had 
lower regional cerebral blood flow in the temporal, parietal, occipital and frontal lobes 
bilaterally, compared with individuals who had never smoked.30 When blood flow reaches a 
critical threshold of cerebral hypoperfusion, brain capillaries can be regionally damaged, and 
the normal release of nitric oxide and glucose, as well as oxygen delivery to the neurons, can 
be impaired.31 These conditions can lead to cerebral metabolic dysfunction, which might 
contribute to the progression of neuronal degeneration.32 Increased oxidative stress caused by 
smoking33,34 is another potential cause of Alzheimer’s disease through enhanced 
neurotoxcity.35  
Nicotine, which is a major component of tobacco smoke, has a neuroprotective effect 
via a reduction of amyloid aggregation and neurotoxicity.36 However, any potential beneficial 
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effect of nicotine is likely to be overwhelmed by the adverse effects of the other components 
of tobacco smoke.33 
The strengths of our current study were its prospective design, and the comprehensive 
nature of cardiovascular surveys, which allowed that the association between smoking and 
risk of dementia is adjusted for important potential confounding variables. Moreover, because 
we used annual cardiovascular surveys that were carried out > 5 years before the endpoint 
determination, severe dementia was unlikely to be present at the time of the risk-factor 
assessment. This would enhance our confidence that smoking behaviour was not influenced 
by subclinical dementia. 
 The major limitations of our study were as follows. First, there might have been a 
residual confounding effect on the association between smoking and risk of dementia. 
Although we adjusted for selected cardiovascular risk, we could not exclude the possible 
influence of unmeasured risk factors such as education level 37 and marital status.38 Second, 
the misclassification for diagnosis of dementia was inevitable. The study had low sensitivity 
but high specificity for the diagnosis of disabling dementia. Thus, cases of disabling dementia 
were less likely to be contaminated by false-positive cases, but the false negative cases were 
likely to exist in the control pool. However, due to the low prevalence of disabling dementia 
(approximately 5-6% of persons aged >65), the contamination by false positive cases in the 
controls may be small. The controls could be contaminated by patients with mild cognitive 
impairments in the present study, which may attenuate the associations. Third, the smoking 
exposure could be misclassified due to self-reporting. However, previous studies showed 
reported that self-reported smoking was fairly reliable. 39, 40 In the present study, we examined 
answer-reanswer reliability with 1-year interval between 1981 and 1994 and found that the 
reliability for self-reported smoking status was high; 97% for never-smokers, 87% for past 
smokers, 93% for current smokers. Fourth, the smoking-dementia associations did not reach 
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statistical significance when we examined two subtypes of dementia, probably due to the low 
statistical power to detect the effects. Fifth, there was a long duration between the time at 
smoking status surveyed and the time at dementia diagnosed, i.e., 6 to 21 years, which would 
make interpretation for the results difficult. However, the results did not change materially 
when the analyses were conducted, stratified by the time duration 6-14 years (n=461) and 
15-21 years (n=163). For example, odds ratios (95% CI) of total dementia in relation to 
current smokers were 1.8 (0.8-4.2) in the time duration of 6-14 years, and 2.0 (0.5-7.6) in the 
time duration of 15-21 years. There were no statistical interactions of two periods with 
smoking status, duration or the amount of smoking. Finally, we did not have imaging studies 
to confirm the subtypes of dementia, and dementia without a history of stroke did not 
necessarily correspond to Alzheimer’s disease. However, the proportion of Alzheimer’s 
disease among persons with dementia without history of stroke was 79% in a previous 
Japanese study,41 suggesting that dementia without history of stroke in present study are likely 
to be Alzheimer’s disease. In contrast, only 2% of persons with history of stroke were 
Alzheimer’s disease in that study, suggesting that Alzheimer’s disease cases were less likely 
to exist in cases of dementia with history of stoke. 
 In conclusion, our prospective study showed that smoking was associated with an 
increased risk of disabling dementia. The smoking-dementia association did not vary by 
stroke history. A dose–response relationship was observed between the duration of smoking 
and the risk, and a two-fold excess risk was found for smokers of >45 years in duration. 
Long-term cigarette smoking may raise the risk of disabling dementia. 
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Table 1. 
Baseline characteristics of study population by case and control. 
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Table 2. 
Odds ratios for dementia according to cigarette smoking status. 
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Table 3.  
Odds ratios for dementia according to years of smoking and pack-years of smoking.
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Table 1 
Age Men
Systolic
blood
pressure
Use of
antihypertensive
medication
BMI Alcohol Intake
Current
Smokers
Serum
Cholesterol Diabetes
Atrial
fibrillation
ST-T
abnormalities
n y % mmHg % kg/m2 % % mmol/L % % %
Total demenita
cases 208 69.1 35.6 139.3* 34.0 23.3 24.0 22.6 * 5.33 9.8 1.9 9.6
control subjects 416 68.6 35.6 135.6 35.0 23.7 22.0 16.1 5.26 6.7 2.4 9.1
Dementia with history of stroke
cases 95 69.4 42.1 142.2* 42.1 23.3 28.4 25.3 5.31 13.8 * 3.2 14.7**
control subjects 190 68.9 42.1 134.4 37.4 23.6 27.4 17.4 5.19 6.0 3.7 7.9
Dementia without history of stroke
cases 113 68.9 30.1 137.0 27.4 23.2 20.2 20.4 5.34 6.6 0.9 5.4
control subjects 226 68.4 30.1 136.6 32.7 23.9 17.5 15.0 5.32 7.2 1.3 10.2
* p  < 0.05 and ** p  < 0.10 (difference between cases and controls)
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Table 2 
 
Current smoker, the number of cigarettes per day
Smoking Status Never Past Smoker Current Smoker < 20 > 20
Total dementia
No. of cases 133 28 47 36 11
No. of control subjects 283 66 67 52 15
Age-,sex-, survey year-matched OR 1.0 1.4(0.6-2.8) 2.2(1.1-4.4) 2.1(1.1-4.3) 2.6(0.9-7.3)
Multivariable OR 1.0 1.5(0.7-3.3) 2.3(1.1-4.7) 2.2(1.1-4.7) 2.7(0.9-8.2)
Dementia with history of stroke
No. of cases 56 15 24 19 5
No. of control subjects 120 37 33 26 7
Age-,sex-, survey year-matched OR 1.0 1.4(0.4-4.5) 2.4(0.8-7.1) 2.4(0.8-7.2) 2.5(0.5-11.9)
Multivariable OR 1.0 1.7(0.5-5.9) 2.4(0.8-7.7) 2.4(0.7-7.9) 2.5(0.4-14.4)
Dementia without history of stroke
No. of cases 77 13 23 17 6
No. of control subjects 163 29 34 26 8
Age-,sex-, survey year-matched OR 1.0 1.3(0.5-3.5) 2.0(0.8-5.0) 2.0(0.8-4.9) 2.6(0.6-11.1)
Multivariable OR 1.0 1.5(0.6-4.3) 2.3(0.9-6.0) 2.2(0.8-5.9) 3.0(0.7-13.8)
Adjusted for body mass index, alcohol use, serum total choresterol, systolic blood pressure, use of antihypertensive medication, diabetes
mellitus, atrial fibrillation and ST-T abnormality.
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Table 3 
Years of smoking P for trend
Smoking Status Never 0<years<34 34<years<45 years>45
Total demenita
No. of cases 133 23 22 30
No. of control subjects 283 45 43 45
Age-,sex-, survey year-matched OR 1.0 1.5(0.7-3.2) 1.8(0.8-4.3) 2.3(1.1-5.2) 0.04
Multivariable OR 1.0 1.7(0.8-3.7) 2.0(0.8-5.2) 2.3(1.0-5.4) 0.04
Dementia with history of stroke
No. of cases 56 8 13 18
No. of control subjects 120 21 25 24
Age-,sex-, survey year-matched OR 1.0 1.3(0.4-4.2) 2.4(0.6-9.5) 3.4(1.0-12.1) 0.05
Multivariable OR 1.0 1.7(0.5-6.0) 2.7(0.5-13.2) 3.0(0.7-12.3) 0.13
Dementia without history of stroke
No. of cases 77 15 9 12
No. of control subjects 163 24 18 21
Age-,sex-, survey year-matched OR 1.0 1.8(0.7-4.6) 1.5(0.5-4.9) 1.7(0.6-4.9) 0.29
Multivariable OR 1.0 2.0(0.7-5.7) 1.8(0.5-6.1) 1.8(0.6-5.7) 0.24
Pack-years of smoking P for trend
Smoking Status Never 0<years<28 28<years<46 years>46
Total demenita
No. of cases 133 31 18 26
No. of control subjects 283 47 42 44
Age-,sex-, survey year-matched OR 1.0 1.9(1.0-3.8) 1.4(0.6-3.2) 2.0(0.8-4.5) 0.23
Multivariable OR 1.0 2.1(1.0-4.3) 1.3(0.5-3.3) 2.1(0.9-5.1) 0.21
Dementia with history of stroke
No. of cases 56 15 10 14
No. of control subjects 120 25 21 24
Age-,sex-, survey year-matched OR 1.0 2.0(0.7-6.1) 1.7(0.5-6.2) 2.2(0.6-7.5) 0.36
Multivariable OR 1.0 2.5(0.8-8.1) 1.3(0.3-5.3) 2.2(0.5-8.5) 0.57
Dementia without history of stroke
No. of cases 77 16 8 12
No. of control subjects 163 22 21 20
Age-,sex-, survey year-matched OR 1.0 1.9(0.8-4.6) 1.1(0.3-3.6) 1.7(0.5-5.8) 0.43
Multivariable OR 1.0 2.1(0.8-5.5) 1.0(0.3-3.8) 2.1(0.6-7.3) 0.33
Adjusted for body mass index, alcohol use, serum total choresterol, systolic blood pressure, use of antihypertensive medication, diabetes mellitus,
atrial fibrillation and ST-T abnormality.
